Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Fallingborg

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Journal of Gastroenterology & Hepatology|May 17, 2006
Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002Bent A Jacobsen, Jan Fallingborg, Henrik H Rasmussen, et al.
Danish Medical Journal|January 6, 2015
Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel diseaseClaus Aalykke, Michael Dam Jensen, Jan Fallingborg, et al.
Scandinavian Journal of Gastroenterology|November 10, 2022
Less prevalent use of biologics for inflammatory bowel disease in patients from Non-Academic hospitals - a Danish register-based study of a region with 580,000 citizensAnne Lund Krarup, Lone Larsen, Alev Büyükuslu Nayeb, et al.
Inflammatory Bowel Diseases|May 13, 2017
Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel DiseaseMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Gut|July 24, 2013
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trialCasper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen, et al.
Digestive Diseases and Sciences|February 13, 2015
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing InfliximabCasper Steenholdt, Jørn Brynskov, Ole Ø Thomsen, et al.
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Nutrients|May 16, 2017
A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised MedicineVibeke Andersen, Uffe Holmskov, Signe Bek Sørensen, et al.
BMJ Open|February 14, 2018
Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicineRobin Christensen, Berit L Heitmann, Karina Winther Andersen, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Gastroenterology & Hepatology|May 17, 2006
Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002Bent A Jacobsen, Jan Fallingborg, Henrik H Rasmussen, et al.
Danish Medical Journal|January 6, 2015
Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel diseaseClaus Aalykke, Michael Dam Jensen, Jan Fallingborg, et al.
Scandinavian Journal of Gastroenterology|November 10, 2022
Less prevalent use of biologics for inflammatory bowel disease in patients from Non-Academic hospitals - a Danish register-based study of a region with 580,000 citizensAnne Lund Krarup, Lone Larsen, Alev Büyükuslu Nayeb, et al.
Inflammatory Bowel Diseases|May 13, 2017
Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel DiseaseMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Gut|July 24, 2013
Individualised therapy is more cost-effective than dose intensification in patients with Crohn's disease who lose response to anti-TNF treatment: a randomised, controlled trialCasper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen, et al.
Digestive Diseases and Sciences|February 13, 2015
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing InfliximabCasper Steenholdt, Jørn Brynskov, Ole Ø Thomsen, et al.
Gastroenterology|April 12, 2016
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on InfectionMette Julsgaard, Lisbet A Christensen, Peter R Gibson, et al.
Inflammatory Bowel Diseases|May 30, 2019
Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth OutcomesMette Julsgaard, Christian L Hvas, Richard B Gearry, et al.
Nutrients|May 16, 2017
A Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised MedicineVibeke Andersen, Uffe Holmskov, Signe Bek Sørensen, et al.
BMJ Open|February 14, 2018
Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicineRobin Christensen, Berit L Heitmann, Karina Winther Andersen, et al.
Pageof 2